RESEARCH MONOGRAPH · KDC-MN-335

Beta-Phenylethylamine (PEA)

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

66/100

Endogenous trace amine with real TAAR1 biology, ferocious first-pass metabolism makes oral use mostly theatrical

Beta-phenylethylamine is the textbook endogenous trace amine and one of the cleaner examples of a molecule whose pharmacology is genuinely interesting and whose typical use case is borderline pointless because of pharmacokinetics.

Mechanism: high-affinity TAAR1 agonist, additional activity at SERT, NET, and DAT as a substrate (causing transporter-mediated release of monoamines, similar to but milder than amphetamine), and some MAO substrate behavior. The TAAR1 biology is the most interesting part: Borowsky and Bunzow's discovery papers in 2001 opened up a whole receptor class that's now being targeted clinically (ulotaront/SEP-363856 for schizophrenia is the most advanced TAAR1 agonist in development). PEA is the prototype endogenous agonist.

The problem with PEA as a research tool or as anything else taken orally is brutal first-pass metabolism. MAO-B in gut and liver chews through it in minutes. Plasma half-life after oral administration is on the order of 5-10 minutes, with peak concentrations that barely move the needle pharmacologically without massive doses. Combine with a MAO-B inhibitor (selegiline historically) and you get meaningful exposure, which is why the old phenelzine and selegiline polypharmacy literature mentioned PEA mechanisms.

What people miss in the consumer-supplement framing: oral PEA hydrochloride at 'energy supplement' doses (100-500 mg) produces essentially no pharmacological effect because almost none of it survives first-pass. If you actually want to see PEA-mediated TAAR1 activity in vivo you either need MAO-B inhibition co-administration, or you use a stable TAAR1 agonist like ulotaront or a research compound like RO5263397.

For research bench work PEA is a useful TAAR1 reference agonist in cell systems and isolated preparations where you dont have to worry about MAO-B. Standard tool in monoamine release assays and TAAR1 expression validation work. The pharmacology in vitro is clean and reproducible.

Sourcing: PEA hydrochloride is widely available, cheap, easy to verify by NMR. The free base is volatile and unstable, you almost always work with the salt.

What we like: foundational trace amine pharmacology, clean in vitro TAAR1 reference compound, the whole TAAR1 receptor field has gotten genuinely interesting recently.

What we dont like is the consumer-supplement use case, which is essentially pharmacologically irrelevant at typical doses. Most of what you read about PEA as a 'natural stimulant' is downstream of the chocolate-and-mood mythology rather than actual pharmacology.

In vitro tool, oral supplement theater.

Evidence: 50
Mechanism: 75
Reliability: 55
Safety: 80
Sourcing: 90
Value: 80
Signal: 40
Staying power: 60

Plain-language summary Intrigue 42 / 100

Beta-phenylethylamine is a small endogenous trace amine your brain makes from the amino acid phenylalanine, present at low nanomolar concentrations and the structural parent of the entire amphetamine class. It is found in chocolate, certain cheeses, and fermented foods, which has fueled folk claims about chocolate and mood. The pharmacology is real (TAAR1 agonism plus secondary monoamine release), but oral PEA is essentially destroyed by MAO-B in minutes, so any practical activity requires combining it with an MAO inhibitor, which is dangerous to do casually. As a standalone supplement the case is weak. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Endogenous trace amine / TAAR1 agonist

An endogenous trace amine; a TAAR1 agonist found at low concentrations in mammalian brain; structurally the parent of amphetamine.

Abstract

Beta-phenylethylamine (PEA; 2-phenylethylamine; CAS 64-04-0; molecular formula C8H11N; molecular weight 121.18) is an endogenous trace amine produced by decarboxylation of L-phenylalanine. The compound is found at low concentrations in mammalian brain (nM range) and in dietary sources including chocolate, cheese, and certain fermented foods. PEA is the prototype TAAR1 agonist (Ki approximately 700 nM at human TAAR1) with secondary effects on monoamine release and inhibition of MAO-B. Plasma half-life is extremely short (approximately 5 to 10 minutes) owing to rapid MAO-B-mediated degradation; exogenous oral PEA is therefore largely inactive without MAO-B inhibition (selegiline combination is used to extend duration). Behavioral and physiological effects parallel amphetamine but with shorter duration and lower potency. Used as the canonical endogenous TAAR1 agonist in trace amine research.

Mechanism of action

Endogenous trace amine TAAR1 agonist; secondary monoamine release. Rapidly degraded by MAO-B, severely limiting oral activity without MAO inhibition.

Reported research dose ranges

Supplement 100 to 500 mg in the published literature (often combined with MAO-B inhibitor for efficacy).

References

Borowsky B, et al. Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci 2001.
Berry MD. Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem 2004.
Janssen PA, et al. Does phenylethylamine act as an endogenous amphetamine? Eur J Pharmacol 1999.

Read the full monograph

The full reference document is available as a research-use-only PDF download. Note: PDFs for newly added compounds may take a few hours to propagate after this article was published.

KDC-MN-335

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Beta-Phenylethylamine (PEA)

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs